A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia

Update Il y a 4 ans
Reference: NCT01559272

Woman and Man

Extract

The purpose of this study is to assess the pharmacokinetics, safety, and tolerability of a paliperidone palmitate 3-month formulation in patients with schizophrenia.


Inclusion criteria

  • Schizophrenia


Links